Cameron, E. and Pauling, L. (1978) Supplemental Ascorbate in the Supportive Treatment of Cancer: Reevaluation of Prolongation of Survival Times in Terminal Human Cancer. Proceedings of the National Academy of Sciences of the United States of America, 75, 4538-4542.
 Chen, Q., Levine, M., Buettner, G.R., et al. (2005) Pharmacologic Ascorbic Acid Concentrations Selectively Kill Cancer Cells: Action as a Pro-Drug to Deliver Hydrogen Peroxide to Tissues. Proceedings of the National Academy of Sciences of the United States of America, 102, 13604-13609.
 Cameron, E. and Campbell, A. (1974) The Orthomolecular Treatment of Cancer. II. Clinical Trial of High-Dose Ascorbic Acid Supplements in Advanced Human Cancer. Chemico-Biological Interactions, 9, 285-315. http://dx.doi.org/10.1016/0009-2797(74)90019-2
 Cameron, E. and Pauling, L. (1976) Supplemental Ascorbate in the Supportive Treatment of Cancer: Prolongation of Survival Times in Terminal Human Cancer. Proceedings of the National Academy of Sciences of the United States of America, 73, 3685-3689. http://dx.doi.org/10.1073/pnas.73.10.3685
 Creagan, E.T., et al. (1979) Failure of High-Dose Vitamin C (Ascorbic Acid) Therapy to Benefit Patients with Advanced Cancer: A Controlled Trial. The New England Journal of Medicine, 301, 687-690.
 Moertel, C.G., et al. (1985) High-Dose Vitamin C versus Placebo in the Treatment of Patients with Advanced Cancer That Have Had No Prior Chemotherapy. The New England Journal of Medicine, 312, 137-141. http://dx.doi.org/10.1056/NEJM198501173120301
 Padayatty, S.J., et al. (2004) Vitamin C: Intravenous Use by Complementary and Alternative Medicine Practitioners and Adverse Effects. Annals of Internal Medicine, 140, 533-537.
 Levine, M., et al. (1996) Vitamin C Pharmacokinetics in Healthy Volunteers: Evidence for a Recommended Dietary Allowance. Proceedings of the National Academy of Sciences of the United States of America, 93, 3704-3709. http://dx.doi.org/10.1073/pnas.93.8.3704
 Buetter, G.R., et al. (2011) Comment on “Pharmacologic Ascorbate Synergizes with Gemcitabine in Pre-Clinical Models of Pancreatic Cancer” i.e. All We Are Saying Is, Give C a Chance. Free Radical Biology and Medicine, 50, 1726-1727. http://dx.doi.org/10.1016/j.freeradbiomed.2011.03.030
 Schleicher, R.L., Carroll, M.D., Ford, E.S. and Lacher, D.A. (2009) Serum Vitamin C and the Prevalence of Vitamin C Deficiency in the United States: 2003-2004 National Health and Nutrition Examination Survey (NHANES). American Journal of Clinical Nutrition, 90, 1252-1263.
 Levine, M., Padayatty, S.J. and Espey, M.G. (2011) Vitamin C: A Concentration-Function Approach Yields Pharmacology and Therapeutic Discoveries. Advances in Nutrition, 2, 78-88.
 Omaye, S.T., Turnbull, J.D. and Sauberlich, H.E. (1979) Selected Methods for the Determination of Ascorbic Acid in Animal Cells. Methods in Enzymology, 62, 3-11.
 Institute of Medicine (2000) Panel on Dietary Antioxidants and Related Compounds, Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. National Academies Press, Washington DC.
 Maserejian, N.N., Giovannucci, E.L., McVary, K.T. and McKinlay, J.B. (2011) Dietary, but Not Supplemental, Intakes of Carotenoids and Vitamin C Are Associated with Decreased Odds of Lower Urinary Tract Symptoms in Men. Journal of Nutrition, 141, 267-273. http://dx.doi.org/10.3945/jn.110.132514
 Thomas, L.D.K., Elinder, C.-G., Tiselius, H.-G., Wolk, A. and Akesson, A. (2013) Ascorbic Acid Supplements and Kidney Stone Incidence among Men: A Prospective Study. JAMA Internal Medicine, 173, 1-2.
 Polidori, M.C., Mecocci, P. and Frei, B. (2001) Plasma Vitamin C Levels Are Decreased and Correlated with Brain Damage in Patients with Intracranial Hemorrhage or Head Trauma. Stroke, 32, 898-902.
 Polidori, M.C., Praticó, D., Ingegni, T., Mariani, E., Spazzafumo, L. and Sindaco, P.D. (2005) Effects of Vitamin C and Aspirin in Ischemic Stroke-Related Lipid Peroxidation: Results of the AVASAS (Aspirin versus Ascorbic Acid plus Aspirin in Stroke) Study. BioFactors, 24, 265-274.